Free Trial

Lixte Biotechnology (LIXTW) Competitors

Lixte Biotechnology logo
$0.03 +0.01 (+32.70%)
As of 01/13/2025

LIXTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Lixte Biotechnology stock or one of its competitors? The main competitors of Lixte Biotechnology include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Lixte Biotechnology vs.

180 Life Sciences (NASDAQ:ATNFW) and Lixte Biotechnology (NASDAQ:LIXTW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.

180 Life Sciences and Lixte Biotechnology both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Lixte BiotechnologyN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Lixte Biotechnology N/A N/A N/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 equaled Lixte Biotechnology'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
Lixte Biotechnology Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Lixte BiotechnologyN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Lixte Biotechnology tied by winning 0 of the 0 factors compared between the two stocks.

Get Lixte Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIXTW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIXTW vs. The Competition

MetricLixte BiotechnologyBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$175.46M$5.25B$8.80B
Dividend YieldN/A3.64%5.07%4.00%
P/E RatioN/A126.2088.0716.96
Price / SalesN/A17,886.761,087.13123.65
Price / CashN/A13.0143.2137.77
Price / BookN/A9.425.054.89
Net IncomeN/A-$20.89M$122.32M$228.40M
7 Day PerformanceN/A1.22%-2.83%-2.25%
1 Month PerformanceN/A1.41%-1.03%-0.41%
1 Year PerformanceN/A149.30%22.93%13.53%

Lixte Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIXTW
Lixte Biotechnology
N/A$0.03
+32.7%
N/A-61.1%$0.00N/A0.004Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+2.9%
N/A+80.7%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-2.7%
N/A+6.6%$0.00N/A0.002Gap Up
High Trading Volume
AIMDW
Ainos
N/A$0.14
+164.7%
N/AN/A$0.00$40,633.000.0040Positive News
High Trading Volume
ALVOW
Alvotech
N/A$3.30
+6.1%
N/A+15.6%$0.00$391.87M0.004Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.09
+4.2%
N/AN/A$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.07
+1.4%
N/AN/A$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.45
flat
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.24
-29.9%
N/A-91.6%$0.00N/A0.008Short Interest ↑
Positive News
Gap Down
CELUW
Celularity
N/A$0.02
+1.0%
N/A+60.7%$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:LIXTW) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners